Shenoy Ashok M, Shiva Kumar T, Prashanth V, Chavan Purushotham, Halkud Rajshekar, Jacob Linu, Govind Babu K, Lokesh G, Pasha Tanveer, Kumar Rekha V
Department of Head and Neck Oncology, Kidwai Memorial Institute of Oncology, Dr.M.H.Marigowda Road, 560029 Bangalore, Karnataka India.
Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka India.
Indian J Otolaryngol Head Neck Surg. 2013 Jul;65(Suppl 1):48-52. doi: 10.1007/s12070-011-0469-2. Epub 2012 Jan 6.
Treatment options for patients with small upper aerodigestive tracts squamous cell carcinoma (T1, T2) with advanced neck disease (N2, N3) is a topic that generates controversy in terms of thereuptic stratagies. We present the retrospective analysis of 109 patients treated, between 1991 and 2008, by "Neck dissection first approach" for N2, N3 neck node, followed by external beam radiotherapy (RT) with or without chemotherapy for the operated neck and the primary, deemed radiocurable. 94 patients completed the planned treatment and formed the material for this study. The primary (tumor) stage was as follows: T1 (29) and T2 (65) commonly arising from oropharynx; the neck nodes were predominantly N2a (n = 54), followed by N2b (n = 26) and N3 (n = 14) disease. Complete nodal clearence was achieved in 89 patients, with no major post operative complications. With a median follow up of 24 months disease free survival of 70% and overall survival of 61% at 5 years. Recurrence at primary site was noted predominantly with pyriform fossa tumors (n = 8), followed by base of tongue (n = 5) and were T2 lesions. Failure in the neck was seen in predominantly N3 nodes, R1 resection and failure to comply with adjuvant treatment. Neck dissection first approach is a valid treatment option that allows a good control of the disease in the neck, where it often fails if only RT is administered, along with preserving the pharyngolaryngeal function. Care should be excercised so that there should be no delay in initiating the RT following surgery.
对于患有上呼吸消化道小鳞状细胞癌(T1、T2)且伴有晚期颈部疾病(N2、N3)的患者,其治疗方案在复发策略方面存在争议。我们对1991年至2008年间接受“先行颈部清扫术”治疗的109例N2、N3颈部淋巴结患者进行了回顾性分析,术后对手术的颈部及被认为可放疗治愈的原发灶进行了外照射放疗(RT),可联合或不联合化疗。94例患者完成了计划治疗并构成了本研究的资料。原发(肿瘤)分期如下:T1(29例)和T2(65例),常见于口咽;颈部淋巴结主要为N2a(n = 54),其次为N2b(n = 26)和N3(n = 14)疾病。89例患者实现了淋巴结完全清除,无重大术后并发症。中位随访24个月,5年无病生存率为70%,总生存率为61%。原发部位复发主要见于梨状窝肿瘤(n = 8),其次为舌根(n = 5),均为T2病变。颈部复发主要见于N3淋巴结、R1切除以及未接受辅助治疗的患者。先行颈部清扫术是一种有效的治疗选择,能够很好地控制颈部疾病,如果仅进行放疗,颈部疾病往往会复发,同时还能保留咽喉功能。应注意术后放疗不要延迟。